Opendata, web and dolomites

CANCER SIGNED

Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CANCER project word cloud

Explore the words cloud of the CANCER project. It provides you a very rough idea of what is the project "CANCER" about.

libraries    combinations    gene    nanoparticle    immunotherapy    tumours    therapy    cancer    disease    optimise    treatment    chemotherapy    surgery    immune   

Project "CANCER" data sheet

The following table provides information about the project.

Coordinator
PERCUROS BV 

Organization address
address: PLESMANLAAN 1
city: LEIDEN
postcode: 2333 BZ
website: www.percuros.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 2˙430˙000 €
 EC max contribution 2˙430˙000 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2017
 Funding Scheme /MSCA-RISE
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2022-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PERCUROS BV NL (LEIDEN) coordinator 324˙000.00
2    ACADEMISCH ZIEKENHUIS LEIDEN NL (LEIDEN) participant 270˙000.00
3    BOSCHIVA MELCHIORRI SRL IT (ROCCA DI PAPA) participant 270˙000.00
4    HELRIK AND LOUW COMPANY LTD UK (LONDON) participant 162˙000.00
5    ASSOCIAZIONE CULTURALE CASTELLI ROMANI GREEN TOUR IT (ARICCIA) participant 108˙000.00
6    AUGEAS ASSOCIAZIONE DI SPORT PROMOZIONE E TURISMO IT (NEMI) participant 108˙000.00
7    ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM NL (ROTTERDAM) participant 108˙000.00
8    JENACELL GMBH DE (JENA) participant 108˙000.00
9    MEDRES-MEDICAL RESEARCH GMBH DE (KOLN) participant 108˙000.00
10    PROGREDUM GMBH DE (KAISERSLAUTERN) participant 108˙000.00
11    TECHNISCHE UNIVERSITEIT DELFT NL (DELFT) participant 108˙000.00
12    TECOBIOSCIENCES GMBH DE (LANDSHUT) participant 108˙000.00
13    THE UNIVERSITY OF SHEFFIELD UK (SHEFFIELD) participant 108˙000.00
14    UNIVERSITA DEGLI STUDI DI CAMERINO IT (CAMERINO) participant 108˙000.00
15    UNIVERSITEIT MAASTRICHT NL (MAASTRICHT) participant 108˙000.00
16    UNIVERSITEIT VAN AMSTERDAM NL (AMSTERDAM) participant 108˙000.00
17    UNIWERSYTET JAGIELLONSKI PL (KRAKOW) participant 108˙000.00

Mappa

 Project objective

During this RISE project we aim to develop nanoparticle-based encapsulated libraries of different immunotherapeutic biomolecules for treatment after surgery as part of a novel cancer management strategy. The current state-of-art for the management of cancer starts with surgery, after identification of an accessible tumour mass. Surgery remains an effective treatment option for many types of cancer today and it is considered curative treatment for most solid tumours. It forms part of a multidisciplinary approach used in conjunction with radiotherapy or chemotherapy. These approaches, however, have several limitations, including inability of surgical resection to affect distal metastatic disease, toxicity to healthy tissues with chemotherapy and lack of effectiveness of radiation therapy in more aggressive tumours. The observation that cancer can relapse months or years after initial surgery implies that micrometastases still resides within the body in a latent state. Our proposal is to take cancer therapy to beyond state-of-art by implementing techniques which will take us into new directions. This includes a) new methods to identify immune gene profiles and biomarkers b) transgenic mouse models where the complex interactions that underlie immune function can be visualised as multiplexed events in real time and c) the use of nanoparticle-based libraries of immune modulating reagent combinations. There are three key objectives within this project: i) to use immune gene signatures to monitor disease progression and therapeutic efficacy of immunotherapy combinations on nanoparticle-based platforms, ii) to optimise the platform to encapsulate libraries of immune components for more personalised, accurate and timely delivery of the payload to its intended target and iii) to optimise the overall cancer management process of image-guided surgery followed by postoperative immunotherapy so that we can ultimately provide a lifetime of protection against cancer.

 Work performed, outcomes and results:  advancements report(s) 

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CANCER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CANCER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

CowficieNcy (2018)

Upgrading and implementing mathematical models to increase nitrogen use efficiency of lactating dairy cows.

Read More  

CONCHA (2018)

The construction of early modern global Cities and oceanic networks in the Atlantic: An approach via OceaN’s Cultural HeritAge

Read More  

IPaDEGAN (2018)

Integrable Partial Differential Equations: Geometry, Asymptotics, and Numerics.

Read More